BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 26, 2003
View Archived Issues
Celltech reorganizes R&D operations
Read More
ICAgen and Abbott renew drug discovery collaboration
Read More
Twelve-month SOHO results reported
Read More
Plexxikon and Phenomix to develop novel drugs for oncology and inflammation
Read More
Increased antitumor activity with new formulations of Panzem
Read More
PPI-2458 inhibits primary tumor growth in mouse model of melanoma
Read More
NSC-703786 induces single-strand breaks and DNA-protein crosslinks in breast cancer cells
Read More
Herstatin stimulates apoptosis in human small cell lung carcinoma cells
Read More
Mechanism of action of the Hsp90 inhibitor CCT-018159 discussed in Boston
Read More
Four related series of Akt kinase inhibitors presented by Merck
Read More
New calpain inhibitors, their preparation and use, reported by Senju team
Read More
Eisai describes new agents with sigma receptor affinity and AChE-inhibitory activity
Read More
Novel analgesic kappa opioid agonists covered by Santen patent
Read More
Novel chemokine CCR3 antagonists prepared and tested at Teijin
Read More
New phenanthrene-based antibacterial agents identified by Japanese researchers
Read More
AnorMED initiates new phase II trial for AMD-3100
Read More
FDA lifts partial clinical hold on phase III trials of Oncophage
Read More
European CPMP hands down positive opinion for Faslodex
Read More
Climara Pro receives FDA approval
Read More
Urethane derivative of pladienolide B with enhanced antitumor activity
Read More
Monarsen receives orphan drug status for myasthenia gravis
Read More
Cholestagel recommended for approval in E.U.
Read More
ImClone seeks approval for Erbitux in Canada
Read More
Bucindolol outlicensed to ARCA Discovery
Read More
Applied Molecular Evolution to become Lilly subsidiary
Read More
NGV1, a VR1 antagonist with analgesic effects in inflammatory pain
Read More
Medarex given go-ahead to begin phase I/II trial of MDX-214
Read More
European CPMP issues positive opinion for oxybutynin transdermal patch
Read More
New analgesic CB2-selective cannabinoids characterized by Pharmos
Read More